New incident report
Incident Report Number: 2011-0834
Registrant Reference Number: PROSAR Case #1-24470404
Registrant Name (Full Legal Name no abbreviations): The Hartz Mountain Corporation
Address: 400 Plaza Drive
City: Secaucus
Prov / State: New Jersey
Country: USA
Postal Code: 07094-3688
Domestic Animal
Country: UNITED STATES
Prov / State: MICHIGAN
PMRA Registration No. PMRA Submission No. EPA Registration No. 2596-126
Product Name: Advanced Care 2 in 1 Flea Tick Cat Spray
Liquid
Yes
Unknown
Site: Animal / Usage sur un animal domestique
Unknown
Animal's Owner
Dog / Chien
Yorkshire Terrier
1
Male
9
5
lbs
Skin
Unknown / Inconnu
>3 days <=1 wk / >3 jours <=1 sem
System
Persisted until death
Yes
Unknown
Died
Treatment / Traitement
(eg. description of the frequency and severity of the symptoms
1-24470404- The reporter, a pet owner, indicates her animal was exposed to an insecticide containing the active ingredient tetrachlorvinphos. The pet owner indicated she applied the product; a flea and tick spray for cats, to her nine year five pound male Yorkshire terrier dog four days prior to the initial contact with the registrant. The owner indicates the animal demonstrated no signs until the day prior to the initial contact with the registrant. The animal was found in the home the day prior laying on his side struggling to breathe. The pet owner indicates when the animal was picked up it screamed in pain. The animal was brought to the veterinarian and treated for what was suspected to be an ¿¿¿allergic reaction? with unknown injectable medications. The pet owner indicated the animal became rigid while the veterinarian was working on it and began having seizures. The pet owner indicates the animal was left in the care of the veterinarian and several hours later they were called and told the seizures were not abating, the animal may have had a ¿¿¿heart attack? and it was ¿¿¿semi-comatose?. The pet owner indicated the veterinarian called in the morning and had stated the animal had died the prior evening. The pet owner was advised the onset and signs seen were both inconsistent with exposure to the active ingredient in the concentration seen. The pet owner was offered registrant supported cholinesterase testing and necropsy. She indicated she was not likely to pursue these diagnostics. No further information is available.
Death